Sartans API Market 2027 By Product, Applications,Impact of covid-19 pandemic. | The Insight Partners

Sartans API Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Valsartan, Irbesartan, Telmisartan, Losartan, Others); Applications (Anti-Hypertension, Anti-Viral, Others),Impact of covid-19 pandemic.

Report Code: TIPRE00015289 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Sartans acts as an angiotensin receptor antagonists that helps in blocking the action of angiotensin that allows the dilation of blood vessels. Angiotensin are the chemicals in the human body that affect the heart by narrowing down the blood vessels that do not allow the required space to the blood to move, resulting in increasing blood pressure, also called as hypertension, and cardiovascular risks. Leading brands in the Sartans API market include Benicar (olmesartan medoxomil), Diovan (valsartan), Micardis (telmisartan), Cozaar (Osartan), EdSartans APIi (Azilsartan), Atacand (candesartan), Teveten (eprosartan), and Avapro (irbesartan). Sartans APIs help in the treatment of conditions, such as, high blood pressure, cardiac failure, chronic kidney diseases, and kidney failure in diabetes.

MARKET DYNAMICS

Market for Sartans API market is driving due to factors such as increasing prevalence of hypertension, cardiovascular disorders and kidney failure in diabetics, increasing geriatric population and commercial availability of Sartans as generic medicines. However, stringent government regulations associated with manufacturing of APIs and strong competition in generic market is expected to hamper the market growth.

MARKET SCOPE

The Sartans API market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Sartans API market with detailed market segmentation by product and application. The Sartans API market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Sartans API market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Sartans API market is segmented on the basis of product and application. Based on product, the market is segmented as Valsartan, Irbesartan, Telmisartan, Losartan, others. Based on application, market is segmented as Anti-Hypertension, Anti-Viral, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Sartans API market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Sartans API market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Sartans API market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Sartans API market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Sartans API market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Sartans API market are anticipated to have lucrative growth opportunities in the future with the rising demand for Sartans API in the global market. Below mentioned is the list of few companies engaged in the Sartans API market.

The report also includes the profiles of key players in Sartans API market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Pfizer
  •  Novartis
  •  Merck
  •  AstraZeneca
  •  Eli Lilly
  •  Sanofi
  •  Bristol-Myers Squibb
  •  Bayer
  •  Huahai Pharmaceutical
  •  Teva Pharmaceutical

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sartans API Market - By Product
1.3.2 Sartans API Market - By Applications
1.3.3 Sartans API Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SARTANS API MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SARTANS API MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SARTANS API MARKET - GLOBAL MARKET ANALYSIS
6.1. SARTANS API - GLOBAL MARKET OVERVIEW
6.2. SARTANS API - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SARTANS API MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. VALSARTAN
7.3.1. Overview
7.3.2. Valsartan Market Forecast and Analysis
7.4. IRBESARTAN
7.4.1. Overview
7.4.2. Irbesartan Market Forecast and Analysis
7.5. TELMISARTAN
7.5.1. Overview
7.5.2. Telmisartan Market Forecast and Analysis
7.6. LOSARTAN
7.6.1. Overview
7.6.2. Losartan Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. SARTANS API MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. ANTI-HYPERTENSION
8.3.1. Overview
8.3.2. Anti-Hypertension Market Forecast and Analysis
8.4. ANTI-VIRAL
8.4.1. Overview
8.4.2. Anti-Viral Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. SARTANS API MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Sartans API Market Overview
9.1.2 North America Sartans API Market Forecasts and Analysis
9.1.3 North America Sartans API Market Forecasts and Analysis - By Product
9.1.4 North America Sartans API Market Forecasts and Analysis - By Applications
9.1.5 North America Sartans API Market Forecasts and Analysis - By Countries
9.1.5.1 United States Sartans API Market
9.1.5.1.1 United States Sartans API Market by Product
9.1.5.1.2 United States Sartans API Market by Applications
9.1.5.2 Canada Sartans API Market
9.1.5.2.1 Canada Sartans API Market by Product
9.1.5.2.2 Canada Sartans API Market by Applications
9.1.5.3 Mexico Sartans API Market
9.1.5.3.1 Mexico Sartans API Market by Product
9.1.5.3.2 Mexico Sartans API Market by Applications
9.2. EUROPE
9.2.1 Europe Sartans API Market Overview
9.2.2 Europe Sartans API Market Forecasts and Analysis
9.2.3 Europe Sartans API Market Forecasts and Analysis - By Product
9.2.4 Europe Sartans API Market Forecasts and Analysis - By Applications
9.2.5 Europe Sartans API Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Sartans API Market
9.2.5.1.1 Germany Sartans API Market by Product
9.2.5.1.2 Germany Sartans API Market by Applications
9.2.5.2 France Sartans API Market
9.2.5.2.1 France Sartans API Market by Product
9.2.5.2.2 France Sartans API Market by Applications
9.2.5.3 Italy Sartans API Market
9.2.5.3.1 Italy Sartans API Market by Product
9.2.5.3.2 Italy Sartans API Market by Applications
9.2.5.4 Spain Sartans API Market
9.2.5.4.1 Spain Sartans API Market by Product
9.2.5.4.2 Spain Sartans API Market by Applications
9.2.5.5 United Kingdom Sartans API Market
9.2.5.5.1 United Kingdom Sartans API Market by Product
9.2.5.5.2 United Kingdom Sartans API Market by Applications
9.2.5.6 Rest of Europe Sartans API Market
9.2.5.6.1 Rest of Europe Sartans API Market by Product
9.2.5.6.2 Rest of Europe Sartans API Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Sartans API Market Overview
9.3.2 Asia-Pacific Sartans API Market Forecasts and Analysis
9.3.3 Asia-Pacific Sartans API Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Sartans API Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Sartans API Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Sartans API Market
9.3.5.1.1 Australia Sartans API Market by Product
9.3.5.1.2 Australia Sartans API Market by Applications
9.3.5.2 China Sartans API Market
9.3.5.2.1 China Sartans API Market by Product
9.3.5.2.2 China Sartans API Market by Applications
9.3.5.3 India Sartans API Market
9.3.5.3.1 India Sartans API Market by Product
9.3.5.3.2 India Sartans API Market by Applications
9.3.5.4 Japan Sartans API Market
9.3.5.4.1 Japan Sartans API Market by Product
9.3.5.4.2 Japan Sartans API Market by Applications
9.3.5.5 South Korea Sartans API Market
9.3.5.5.1 South Korea Sartans API Market by Product
9.3.5.5.2 South Korea Sartans API Market by Applications
9.3.5.6 Rest of Asia-Pacific Sartans API Market
9.3.5.6.1 Rest of Asia-Pacific Sartans API Market by Product
9.3.5.6.2 Rest of Asia-Pacific Sartans API Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Sartans API Market Overview
9.4.2 Middle East and Africa Sartans API Market Forecasts and Analysis
9.4.3 Middle East and Africa Sartans API Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Sartans API Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Sartans API Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Sartans API Market
9.4.5.1.1 South Africa Sartans API Market by Product
9.4.5.1.2 South Africa Sartans API Market by Applications
9.4.5.2 Saudi Arabia Sartans API Market
9.4.5.2.1 Saudi Arabia Sartans API Market by Product
9.4.5.2.2 Saudi Arabia Sartans API Market by Applications
9.4.5.3 U.A.E Sartans API Market
9.4.5.3.1 U.A.E Sartans API Market by Product
9.4.5.3.2 U.A.E Sartans API Market by Applications
9.4.5.4 Rest of Middle East and Africa Sartans API Market
9.4.5.4.1 Rest of Middle East and Africa Sartans API Market by Product
9.4.5.4.2 Rest of Middle East and Africa Sartans API Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Sartans API Market Overview
9.5.2 South and Central America Sartans API Market Forecasts and Analysis
9.5.3 South and Central America Sartans API Market Forecasts and Analysis - By Product
9.5.4 South and Central America Sartans API Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Sartans API Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Sartans API Market
9.5.5.1.1 Brazil Sartans API Market by Product
9.5.5.1.2 Brazil Sartans API Market by Applications
9.5.5.2 Argentina Sartans API Market
9.5.5.2.1 Argentina Sartans API Market by Product
9.5.5.2.2 Argentina Sartans API Market by Applications
9.5.5.3 Rest of South and Central America Sartans API Market
9.5.5.3.1 Rest of South and Central America Sartans API Market by Product
9.5.5.3.2 Rest of South and Central America Sartans API Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SARTANS API MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SARTANS API MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANOFI
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BRISTOL-MYERS SQUIBB
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BAYER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. HUAHAI PHARMACEUTICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. Novartis
3. Merck
4. AstraZeneca
5. Eli Lilly
6. Sanofi
7. Bristol-Myers Squibb
8. Bayer
9. Huahai Pharmaceutical
10. Teva Pharmaceutical
TIPRE00015289
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking